6919 fundamentals
An in-depth look to CALIWAY BIOPHARMACEUTICALS CO LTD operating, investing, and financing activities
6919 free cash flow for Q4 24 is -42.31 M TWD. For 2024, 6919 free cash flow was -532.3 M TWD and operating cash flow was -522.31 M TWD.
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM